pone.0197189.g006.tif (420.91 kB)

A2AR-/- γδ T cells were unable to suppress Foxp3+ T cell response.

Download (420.91 kB)
figure
posted on 17.05.2018 by Dongchun Liang, Jeong-Im Woo, Hui Shao, Willi K. Born, Rebecca L. O'Brien, Henry J. Kaplan, Deming Sun

A) CD3+ responder T cells isolated from immunized TCR-δ-/- mice were cultured with 1 ng/ml recombinant IL-2 in the presence or absence of γδ T cells isolated from immunized B6 or A2AR-/- mice and subsequently stained with a PE-labeled anti-Foxp3 antibody. B) Pretreatment of A2AR+/+ γδ T cells with an A2AR antagonist (SCH 58261) abolished the enhancing effects. CD3+ responder T cells isolated from immunized TCR-δ-/- mice were cultured with 1 ng/ml recombinant IL-2 for 5 days, in the absence (left panel) or presence (middle and right panels) of γδ T cells that were treated (right panel) or untreated with an A2AR antagonist. Foxp3+ T cells in the cultures were identified. C) Blockade of high-affinity IL-2 receptor CD25 by monoclonal antibody (PC61) did not affect the inhibiting effect of γδ T cells. CD3+ responder T cells isolated from immunized TCR-δ-/- mice were cultured with 1 ng/ml recombinant IL-2 for 5 days, in the absence (left panel) or presence (three right panels) of activated γδ T cells that were treated as indicated.

History

Licence

Exports